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The acid-induced and guanidinium chloride-induced conformational transitions in human carbonic anhy- 
drase B have beerranalyzed. A structural form was detected at pH 3, which has a higher secondary structural 
order than the native enzyme but little tertiary structure. The enzyme dissolved in an intermediate concen- 
tration of the denaturant guanidinium chloride (1 M at pH 7.5) also adopts a similar conformational state. 
This form, denoted as the intermediate form I, possesses most of the characteristics defined for the molten 
globular state of globular proteins and might serve as the embryonic structural intermediate during the self- 
organization of the protein into its functional native form. 
Globular protein renaturation Molten globular form 
1. INTRODUCTION 
The delineation of the strategy that an 
unordered protein chain adopts to fold into its 
functional and native form in a short time has been 
a subject of considerable interest. A hierarchy of 
the folding process, nucleation sites and domains, 
embryonic structures and discrete intermediates 
have been suggested [1,2]. A recent suggestion is 
that of a molten globular form [3-81 (the term has 
been proposed in [7]), which forms an intermediate 
state in the self-organisation of globular proteins. 
Such a molten globular state has been reported for 
several globular proteins [3-81. We report here our 
results on the unfolding-refolding of human car- 
bonic anhydrase B (HCAB), induced by acid and 
by the denaturant guanidinium chloride (GuCl), 
which suggest the presence of such a molten 
globular intermediate state in this enzyme, which 
has significant secondary, but little tertiary, struc- 
tural order, which is devoid of esteratic activity 
and which can be converted into the native and ac- 
tive form. 
* To whom correspondence should be addressed 
Human carbonic anhydrase B CD spectroscopy 
HCAB, present in human erythrocytes, is a 
single chain of about 260 amino acids (no disulfide 
bridges), having one Zn2+ at the active site, and 
catalyzing the reversible hydration of CO2 [9]. Its 
activity can be assayed either by determining the 
hydrolysis rate of p-nitrophenyl acetate [lo] or by 
the hydration reaction of CO2 into HCOY or vice 
versa [9]. The isoenzyme of HCAB, termed 
HCAC, is also present in erythrocytes; while there 
is only 59% homology between the sequences of 
HCAB and HCAC, their 3-dimensional structures 
are very similar [ 1 l-131. Early spectroscopic 
studies on HCAB and HCAC [14,15] have sug- 
gested that stable and partly unfolded conforma- 
tions of the enzymes might occur at intermediate 
concentrations of denaturants. Carlsson et al. 
[16,17] have studied in detail the unfolding and 
refolding of these molecules and suggested that in- 
correctly folded states of the molecule might occur 
in 1.7 M GuCl. 
It is of interest in this connection to note that 
bovine carbonic anhydrase B (BCAB) is 
remarkably similar in its 3-dimensional conforma- 
tion to the human B enzyme HCAB, despite the 
45% variations or heterology in their amino acid 
sequences [ 1 1 , 181. Kinetic studies on the unfolding 
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and renaturation of BCAB [19,20] have revealed 
several conformational species involved in the 
folding pathway. That a molten globular in- 
termediate accumulates in the folding of BCAB 
has been reported by Dolgikh et al. [8]. 
The overall conformational similarity between 
HCAB and its bovine analog has prompted us to 
investigate whether any of the intermediate struc- 
tural forms observed in HCAB bear any structural 
resemblance to the molten globular state. We have 
also attempted to compare the properties of the 
acid-induced form and the GuCl induced forms of 
the enzyme HCAB. 
2. MATERIALS AND METHODS 
HCAB was obtained from Sigma (lot 
112F-9305) and its purity and intactness confirmed 
by PAGE and SDS-PAGE to be satisfactory. The 
esteratic activity of the enzyme was determined us- 
ing p-nitrophenyl acetate as the substrate [21]. The 
rate of hydrolysis of 0.4 mM substrate in 75 mM 
Tris-sulfate (pH 7.5) buffer at 25°C was followed 
by measuring the absorbance of 400 nm. When the 
assay solution contained GuCl, appropriate cor- 
rection was made by using the blocks containing 
the proper concentrations of the denaturant. 
Circular dichroism (CD) spectral measurements 
in the near-ultraviolet (UV) and far-UV regions 
were made using a Jasco-20 spectropolarimeter 
that was previously calibrated with appropriate 
standards. The mean residue molar ellipticity is ex- 
pressed in degree 1 cm*. dmol-‘. All measurements 
were made at 25°C. The concentration chosen for 
CD studies is 0.8 mg/ml of HCAB, where self- 
aggregation of the protein does not occur. 
3. RESULTS AND DISCUSSION 
3.1. Acid-induced conformation of HCAB 
The monitoring of the far-UV (below 240 nm) 
and the near-UV CD bands (310-250 nm) of the 
enzyme offers information about its secondary and 
tertiary structural features respectively, such as the 
helical or &structure content, and the aromatic 
amino acid clustering and environment [9,14,22]. 
Fig.1 reveals that the native structure of HCAB 
has about the same structural features as its bovine 
analog [20]. The far-UV CD spectrum is compati- 
ble with little helical order and about 35Yi p- 
Fig. 1. Far-UV (left) and near-UV (right) CD profiles of 
human carbonic anhydrase B. (0) Native, neutral pH; 
(- --) in 1 M GuCl; (0) in 5 M &Cl; and (x) at pH 
3.0. 
structure while the characteristic near-UV CD 
bands originate from the aromatic amino acid 
clustering in the tertiary structure. Upon denatura- 
tion (with 5 M GuCl), the enzyme loses all its ter- 
tiary structure (fig.1, a featureless near-UV CD 
curve) and backbone order (monotonically 
decreasing far-UV CD spectrum). 
Acidification of HCAB to pH 3 causes signifi- 
cant CD spectral changes. The intensification and 
slight blue-shifting of the 215 nm band suggest 
that the acid form has a different secondary struc- 
tural order from the native form, but the near-UV 
CD spectrum has lost much of its features, 
resembling the unordered form. The reduction of 
ellipticity of the aromatic bands suggests a 
substantial loss in the tertiary structure around 
these structures. The molecule was found to be en- 
zymatically inactivated at pH 3 since no esteratic 
activity was observed here. Efforts to renature the 
enzyme by restoring the pH to neutrality were un- 
successful since it led to aggregation and precipita- 
tion [20]. The solubility of HCAB at pH 3 already 
being low, hydrodynamic characterization of its 
compactness was not possible [23]. 
3.2. HCAB in 1.2 M GuCl 
Fig.1 also shows the changes that occur in the 
CD profiles of HCAB upon addition of increasing 
amounts of the denaturant GuCl. Addition of as 
little as 0.5 M GuCl already causes a significant 
reduction in the tertiary structure of the molecule 
(near-UV CD bands) and at 1.2 M GuCl the ter- 
tiary structure is essentially disrupted. However, 
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the secondary structure, as monitored by far-UV 
CD bands, appears to be promoted even more in 
1.2 M GuCl than in the native form - a situation 
similar to what is obtained when the enzyme is 
acidified to pH 3. Further increase in the 
denaturant concentration leads to expected loss of 
the secondary structure as well. Thus, there is a 
non-coincidence in the transition curves of the en- 
zyme as monitored by near-UV CD and far-UV 
CD bands. The resemblance between the CD spec- 
tra of the enzyme in 1.2 M GuCl and at pH 3 sug- 
gests a similarity in the structure of the enzyme 
under both conditions. It thus appears that HCAB 
might adopt an intermediate conformational form 
I, during its denaturation and that this form 
possesses a pronounced secondary structure, but 
little or no tertiary structure. In light of the obser- 
vations that such an I form exists in BCAB [S], 
which can be transformed into the native (N) or the 
unfolded (U) forms, we undertook a kinetic study 
of the conformational transitions in HCAB be- 
tween the N, U and the putative I forms. 
3.3. Time dependence of structural transitions 
The enzyme aggregates and precipitates when 
one attempts to renature it from the acid-expanded 
form directly, just as the bovine analog does [20]. 
I.0 
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However, it is possible to take the GuCl-denatured 
HCAB, dilute the denaturant concentration to 
very low amounts (0.1-0.4 M GuCl) and rever- 
sibly renature and reactivate it. Fig.2a shows that 
such a U-N transition of HCAB is rapid with 
respect o the recovery of the secondary structure. 
The ellipticity at 222 nm of the native form is 
largely obtained within the dead-time of 2 min of 
diluting the GuCl concentration and recording the 
CD spectrum. However, it is slower with respect o 
its tertiary structure as monitored by the recovery 
of the native-form near-UV CD spectrum (half- 
time of the order of 10 min), and the esteratic ac- 
tivity was found to recover to 90% of its value in 
the native form in about 60 min. This transition 
may be summarized as: 
fast (222. 270. EA) 
N u 
0.1-0.4 M GuClfast (222), slow (270,EA)5 M GuCI 
where ‘fast’ refers to a rapid change in the proper- 
ty studied, i.e., within the dead-time of 2 min, 
‘slow’ to a time scale of the order IO-20 min, 222 
and 270 to the CD band intensities at 222 and 
270 nm, and EA to the specific activity of the 
enzyme. 
When the kinetics of the N-I form was 
o-01 I I I I I 
0 IO 20 30 40 50 E 
Time in min 
> 
Fig.2. (a) Time dependence of the recovery of the native structure in HCAB upon renaturing the molecule from the 
unfolded (U) state in 5 M GuCl to the native form (N) in 0.5 M &Cl; as monitored by CD at (m) 270 nm and (0) 
222 nm. (b) Time dependence of the recovery of native structure in HCAB during the transition from the intermediate 
(I) form in 1.2 M GuCl to the native (N) form in 0.12 M GuCI; (e) as monitored by CD at 270 nm, and (x) by the 
esteratic activity. 
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followed, it was seen that the CD spectral changes 
(fig.1) occurred with a half-time of the order of a 
few minutes, while the change from the I-U 
form occurred within 2 min. The I form has no 
esteratic activity. It has already been pointed out 
that the far-UV CD band changes (at 222 nm) are 
fast upon going from U to I. 
Fig.2b illustrates the time profile of the transi- 
tion I-N, as monitored by the near-UV CD 
spectral changes (270 nm) and the recovery of the 
esteratic activity. The CD bands around 270 nm 
are seen to recover to that of the N form with a tl/z 
of the order of lo-12 min, while the esteratic ac- 
tivity is recovered to that of the native state in 
about 40 min. 
It is thus possible to summarise the structural 
transitions in HCAB, brought about by various 
concentrations of GuCl in the medium, in the form 
of scheme 1, identical to that proposed by Ptitsyn 
and co-workers [8] for BCAB: 
$&g#y(;;r;;y 
N, LU 
(0 IMGuCI) fost(2221, rlow(270, EA) (SM GuCI) 
Scheme 1. Scheme of the kinetics of the transitions in 
HCAB between the native (N), intermediate (1) and 
unfolded (U) forms. 
The implication of an intermediate form, I, is 
consistent with the kinetic behavior of the enzyme, 
and also with its spectroscopic properties. Carlsson 
et al. [16,17] suggested that an ‘incorrectly folded’ 
form of HCAB might accumulate at medium con- 
centrations of GuCl. Henkens et al. [24] 
characterized an intermediate form of the bovine 
enzyme at 2 M GuCI; McCoy and Wong [20] have 
shown that the kinetics of renaturation of the same 
enzyme is consistent with the presence of in- 
termediate forms; and Ptitsyn’s group has sug- 
gested that bovine carbonic anhydrase has a 
molten globular form in 2 M GuCl, similar to 
those obtained in a few other globular proteins [8]. 
Such a molten globule is defined as possessing a 
secondary structure comparable to the native 
form, but lacking tertiary structural features, or 
cooperative thermal melting. It is thought to have 
pronounced fluctuations in its 3-dimensional struc- 
ture, due to a slight decrease in its molecular 
volume leading to a sharp decrease of the van der 
Waals interactions [5]. 
The I form that we have studied in HCAB ap- 
pears to be such a molten globule since it shares 
many of its characteristics. A few more points are 
worthy of note: (i) The acid-induced form of 
HCAB might very well be a molten globular struc- 
ture since it shares several properties with the form 
obtained at 1 M GuCl. (ii) The observations that 
the N-U transition of HCAB occurs at a lower 
GuCl concentration when monitored by the CD 
changes at 270 nm than those at 220 nm, and that 
the secondary structure is recovered faster than the 
tertiary structure during the U-N, U-I, or 
I-N transitions indicate that the secondary 
structure is formed earlier in the enzyme molecule. 
Thus, the I form appears to be a likely candidate 
for the ‘embryonic form’ with secondary structural 
order, that has been postulated as the intermediate 
form in the self-organization of a globular protein 
[2]. (iii) The I form of HCAB occurs at around 
1 M GuCl while that of the bovine enzyme is seen 
around 2 M GuCl. This appears to be a reflection 
of the differences in their primary structure. (iv) 
The fact that the I form is identifiable in both 
HCAB and BCAB (which have only 55% 
homology between them) suggests that such a form 
might also occur in human carbonic anhydrase C, 
which has about 60% homology with the enzyme 
B, and that the entire family of carbonic 
anhydrases might self-organize through the I form 
in their folding pathway. 
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